Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD
International Journal of COPD, 07/01/09
Hilleman DE et al. - The long-term use of inhaled anticholinergic agents has recently been suggested to be associated with an excess risk of adverse cardiovascular (CV) outcomes in patients with COPD. The relative risks for serious CV events, heart failure, and myocardial infarction were all significantly lower with tiotropium than placebo.
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Omega-3 fatty acids and heart failure
Current Atherosclerosis Reports, 11/12/09
Vitamin D and cardiovascular disease
Current Atherosclerosis Reports, 11/12/09
Effectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)
The American Journal of Cardiology, 11/05/09
Sponsor
Article Search
Sponsor


See Latest Articles


